Split History
| Home |
| Free Dividend Report |
| Stock Splits Calendar |
| ALKS Stock Split History |
| Preferred Stock Newsletter |
| ALKS Options Chain |
| Stock Message Boards |
Alkermes (ALKS) has 1 split in our ALKS split history database. The split for ALKS took place on May 15, 2000. This was a 2 for 1 split, meaning for each share of ALKS owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split.
When a company such as Alkermes splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the ALKS split history from start to finish, an original position size of 1000 shares would have turned into 2000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Alkermes shares, starting with a $10,000 purchase of ALKS, presented on a split-history-adjusted basis factoring in the complete ALKS split history.
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 06/14/2016 | |
| End date: | 06/12/2026 | |
| Start price/share: | $41.99 | |
| End price/share: | $44.28 | |
| Dividends collected/share: | $0.00 | |
| Total return: | 5.45% | |
| Average Annual Total Return: | 0.53% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $10,542.82 | |
| Years: | 10.00 | |
 |
| About Alkermes |
| Alkermes plc is a global biopharmaceutical company that seeks to develop medicines in the field of neuroscience. Co. has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. According to our ALKS split history records, Alkermes has had 1 split. |
| ALKS Split History Table | |
| Date | Ratio |
| 05/15/2000 | 2 for 1 |
| Healthcare Stock Splits |
| ALKS is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:
ALPN Split History Also explore: ALKS shares outstanding history
|
Free ALKS Email Alerts:
